
About the "Taiwan-Japan Accelerator Program 2025
Taiwan's startup ecosystem is growing and developing at an astonishing rate due to a number of strategic government policies, an increase in investment funds flowing into the ecosystem, and the active involvement of companies during the startup phase.
Following the FY2022 and FY2023 programs, this program will be held with the aim of creating business partnerships and new business opportunities with Japanese companies in the Japanese market, where both the public and private sectors have been working together for many years, in order to contribute to further growth support for Taiwanese start-ups.
Three Japanese companies with a proven track record of collaboration and business partnerships with many startups have been selected to participate in the 2025 fiscal year. By combining the diverse and abundant management resources of Japanese companies with the fresh ideas and innovative technology of Taiwanese startups, we will work to create innovations that transcend national borders.
In conjunction with the launch of this program, a dedicated website* was opened on the Creww website to disclose the management resources of the three participating companies. All matching and commercialization activities, including proposals for collaboration from Taiwanese startups that have passed the document screening process, will be held online, and will be promoted through the accompaniment and support of Creww and Creww Taiwan.
Creww will continue its efforts to create innovation on a global scale by collaborating with overseas startup ecosystem centers and supporting matchmaking between Japanese companies and overseas startups.
*Open only to eligible Taiwanese startups
Participating companies (in alphabetical order)
AstraZeneca Corporation
<About i2.JP
i2.JP was launched in Japan in November 2020 as a member of AstraZeneca's global healthcare innovation hub, A.Catalyst Network, and is actively promoting open innovation activities.
i2.JP brings together startups, healthcare professionals, local governments, academia, and private companies to work toward solving problems in the healthcare field and to create practical, optimal solutions together through collective knowledge.
Our mission is to take on the challenge of four issues: achieving "patient-centeredness," providing added value to healthcare professionals, discovering and fostering new technologies that contribute to patients and healthcare professionals, and optimizing the healthcare system.
As for i2.JP, https://www.i2jp.net/ for more information.
<About AstraZeneca
AstraZeneca is a science-oriented global biopharmaceutical company engaged in the discovery, development, manufacturing, and marketing and sales activities of prescription drugs, primarily in biotechnology and pharmaceuticals comprising oncology, rare diseases, cardiovascular, renal and metabolic diseases, and respiratory and immune diseases.
Headquartered in Cambridge, England, the company operates in more than 100 countries and its innovative medicines are used by many patients worldwide.
For more information, please contact https://www.astrazeneca.com Or follow us on Twitter @AstraZeneca (English only).
Shimizu Corporation
<Company Profile
Shimizu Corporation was founded in 1804. Kisuke Shimizu I, a carpenter from Etchu-Toyama, started his business in Kanda Kaji-cho, Edo.
From the time Kisuke I founded the company, his goal was "to work with sincerity and wholehearted devotion, to create good products and to be trusted. Today, Shimizu Corporation is constantly pursuing new knowledge and technologies to meet the needs of our customers and society.
Mitsubishi Corporation
<Company Profile
Mitsubishi Corporation (MC) is developing diversified businesses in a wide range of industries through its eight business groups: Energy & Environment, Materials Solutions, Mineral & Metal Resources, Social Infrastructure, Mobility, Food Industry, Smart-Life Creation (S.L.C.), and Power Solutions. We are developing diversified businesses in a wide range of industries.
Outline of "Japan-Taiwan Accelerator Program 2025
| Entry period | Monday, March 10, 2025 - Monday, March 31, 2025 |
| 2. Target Companies | Startup based in Taiwan. Any industry. |
| Participating companies | 3 Japanese companies |
| 4. sponsorship | Creww, Creww Taiwan |
About Creww Taiwan
| name of company | Creww Taiwan |
| Location | 34F, No.100 Song Ren Road, Taipei City |
| representative | Sally Lin |
| Business Overview | Support for Taiwanese startups entering the Japanese market, support for Japanese startups entering the Taiwanese market |
| uniform resouce locator | https://crewwtw.com/ |
Creww Corporation|Company Profile

Creww, Inc. is a total support company for startups, entrepreneurs, business companies, and individuals who want to take on new challenges. Creww Inc. is a total support company for startups, entrepreneurs, business companies, and individuals who want to take on challenges, providing a variety of services that match the needs of each individual.
Since its establishment in 2012, we have held more than 500 open innovation programs between companies and local governments and startups, and have achieved about 1,500 collaborations, making us one of the largest in Japan. About 8,500 startups are registered on the open innovation platform that we operate.
Currently, we are promoting the creation of open innovation not only in Japan, but also in South Korea, Taiwan, and globally to contribute to the development of the startup ecosystem in Asia.
| name of company | Creww Corporation |
| Establishment | August 13, 2012 |
| Location | 4F 1-19-9 Dogenzaka, Shibuya-ku, Tokyo |
| representative | Representative Director: SORATO IJICHI |
| Business Overview | Operation of one of the largest open innovation platforms in Japan. Operation of a startup community. |
| uniform resouce locator | https://creww.in/ |










